Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial

OBJECTIVE: To assess the safety and efficacy of port-locking with heparin every 2 months vs. every 4 months and vs. saline solution every 2 months in patients with cancer not receiving active chemotherapy. The hypothesis stated that locking with heparin at four-month intervals and saline at two-mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Cia-Arriaza, Melania, Cabrera-Jaime, Sandra, Cano-Soria, Rosario, Manzano-Castro, Mireia, Domínguez-Gómez, Margarita, Prieto-Arenas, Dolores M., Benito-Yagüe, Angeles, Sánchez-Martín, Adela, González-Alonso, Cristina, Fernández-Ortega, Paz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345785/
https://www.ncbi.nlm.nih.gov/pubmed/35935884
http://dx.doi.org/10.1016/j.apjon.2022.100085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345785/
https://www.ncbi.nlm.nih.gov/pubmed/35935884
http://dx.doi.org/10.1016/j.apjon.2022.100085

Ejemplares similares